Funding, launches and regulatory moves across the neurotech startup map, delivered every two weeks.
Subscribed. Check your inbox to confirm.
•
Neurofounders Insights
$ Funding -
Seed
MODALITY
Nerve stimulator
FORM FACTOR
Wearable (body)
INTERFACE DEPTH
Non-invasive
INDICATION
Other
TARGET USER
Patients
REGULATORY STAGE
FDA cleared (510k)
Encora Therapeutics is positioned in peripheral neuromodulation for movement disorders, particularly essential tremor. Its non-invasive approach competes with Cala Health but remains earlier in clinical validation.
.svg)
